Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Pembrolizumab plus docetaxel used to treat patients with metastatic castration-resistant prostate cancer

Prof Daniel Petrylak - Yale University Cancer Center, New Haven, USA
Pembrolizumab plus docetaxel used to treat patients with metastatic castration-resistant prostate cancer ( Prof Daniel Petrylak - Yale University Cancer Center, New Haven, USA )
6 Mar 2023

INTRAGO: Intraoperative radiotherapy in newly diagnosed glioblastoma

Dr Frank Giordano - University of Heidelberg, Heidelberg, Germany
INTRAGO: Intraoperative radiotherapy in newly diagnosed glioblastoma ( Dr Frank Giordano - University of Heidelberg, Heidelberg, Germany )
3 Mar 2023

IORT at hospital Del Mar Barcelona in Spain

Dr Javier Sanz - Hospital Del Mar, Barcelona, Spain
IORT at hospital Del Mar Barcelona in Spain ( Dr Javier Sanz - Hospital Del Mar, Barcelona, Spain )
3 Mar 2023

IORT at University Hospital Augsburg in Germany

Dr Klaus-Henning Kahl - University Hospital Augsburg, Augsburg, Germany
IORT at University Hospital Augsburg in Germany ( Dr Klaus-Henning Kahl - University Hospital Augsburg, Augsburg, Germany )
3 Mar 2023

Raising awareness of the burden of cervical cancer in the Eastern Mediterranean region

Dr Ibtihal Fadhil - Eastern mediterranean NCD Alliance, Kuwait City, Kuwait
Raising awareness of the burden of cervical cancer in the Eastern Mediterranean region ( Dr Ibtihal Fadhil - Eastern mediterranean NCD Alliance, Kuwait City, Kuwait )
2 Mar 2023

Improving access to palliative care by enhancing primary care services in an upper middle-income country

Dr Malar Velli Segarmurthy - Ministry of Health Malaysia, Putrajaya, Malaysia
Improving access to palliative care by enhancing primary care services in an upper middle-income country ( Dr Malar Velli Segarmurthy - Ministry of Health Malaysia, Putrajaya, Malaysia )
28 Feb 2023

Genomic profiling of penile squamous cell carcinoma reveals major biomarkers for efficacy of immunotherapy

Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy
Genomic profiling of penile squamous cell carcinoma reveals major biomarkers for efficacy of immunotherapy ( Prof Andrea Necchi -  The Vita-Salute San Raffaele University, Milan, Italy )
23 Feb 2023

Comparative cost-effectiveness of alternative imaging and surveillance schedules for testicular seminoma

Prof Robert Huddart - Royal Marsden NHS Foundation Trust, London, UK
Comparative cost-effectiveness of alternative imaging and surveillance schedules for testicular seminoma ( Prof Robert Huddart - Royal Marsden NHS Foundation Trust, London, UK )
19 Feb 2023

Nivolumab and salvage nivolumab plus ipilimumab for aRCC

Prof Michael Atkins - Georgetown Lombardi Comprehensive Cancer Center, Georgetown, USA
Nivolumab and salvage nivolumab plus ipilimumab for aRCC ( Prof Michael Atkins - Georgetown Lombardi Comprehensive Cancer Center, Georgetown, USA )
18 Feb 2023

Anti-PSMA antibody radiolabeled with 177Lu improves MFS in high-risk nmCRPC

Prof Scott Tagawa - Weill Cornell Medicine, New York City, USA
Anti-PSMA antibody radiolabeled with 177Lu improves MFS in high-risk nmCRPC ( Prof Scott Tagawa - Weill Cornell Medicine, New York City, USA )
18 Feb 2023

Erdafitinib demonstrates efficacy in intermediate-risk non–muscle-invasive bladder cancer with FGFR alterations

Prof Siamak Daneshmand - University of Southern California, Los Angeles, USA
Erdafitinib demonstrates efficacy in intermediate-risk non–muscle-invasive bladder cancer with FGFR alterations ( Prof Siamak Daneshmand - University of Southern California, Los Angeles, USA )
18 Feb 2023

Cell-free utDNA may predict transurethral resection of bladder tumour pathology in non–muscle invasive bladder cancer

Dr Kyle Rose - Moffitt Cancer Center, Florida, USA
Cell-free utDNA may predict transurethral resection of bladder tumour pathology in non–muscle invasive bladder cancer ( Dr Kyle Rose - Moffitt Cancer Center, Florida, USA )
18 Feb 2023